§ Mr. Jim CunninghamTo ask the Secretary of State for Health what his policy is on the use of interferon beta and glatiramer in the treatment of multiple sclerosis; and if he will make a statement. [17248]
§ Ms Blears[holding answer 26 November 2001]: We are currently holding discussions with the manufacturers to consider a range of options under which drugs for multiple sclerosis might be made available under the national health service. One option is a 'risk-sharing' scheme which will evaluate their clinical and cost effectiveness, and until these discussions are concluded we cannot provide the information requested.